EP. 12: Emerging Treatments in SCLC: Triplets + Limited-Stage Disease
August 19th 2021
Anne Chiang, MD, PhD, reviews the study design of 2 clinical trials, adding a third agent to the standard-of-care regimen of chemotherapy plus I/O; Stephen Liu, MD, discusses clinical trials in limited-stage disease.